about
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...
Read More
1.05
0.03
(2.94%)
580.8K
XNAS Volume
XNAS 12 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
InflaRx N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..